• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA Green Lights Roche's Polivy in First-Line DLBCL

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 20, 2023 at 11:02: AM
via The FDA has approved Roche-subsidiary Genentech’s Polivy (polatuzumab vedotin-piiq), as part of a five-drug regimen, for the first-line treatment of patients with diffuse large B-cell lymphoma (DLBCL), the company announced Thursday.

article source
 

<



Similar threads

cafead
Immunovant Shares Touch 52-Week High After FDA Green Lights IMVT-1402 Study
Replies
0
Views
181
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
In a surprise approval, FDA green-lights Incyte&#039;s PD-1 inhibitor to treat rare cancer type
Replies
0
Views
321
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA green lights booster dose of Pfizer vaccine for older, more vulnerable Americans
Replies
0
Views
138
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
Replies
0
Views
313
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA green lights AstraZeneca&#039;s asthma drug Fasenra for self-administration
Replies
0
Views
388
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote